| Value | ₹4.20 Cr |
|---|---|
| Execution period | 3 years from vesting |
BSE filing, NSE: AURUM. Summary written from the filing by ALFA Finder's alert engine.
Aurum Proptech Ltd: key numbers
- Share price
- ₹213.49
- Market cap
- ₹2,057 Cr
- Revenue (annual)
- ₹381.1 Cr
- Net profit (annual)
- ₹1.90 Cr
- P/E (TTM)
- 29.6×Sector 22.9×
- Promoter holding
- 38.09%-9.80% QoQ
- FII holding
- 0.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aurum Proptech Ltd
All →Aurum Proptech Promoter Buying: ₹0.21 Cr
Promoter Aurum RealEstate Developers bought 10,000 Aurum PropTech shares in the market, worth ₹0.21 Crore. Its stake rose from 38.11% to 38.12%.
- Value
- ₹0.21 Cr
- Promoter stake change
- +0.01%
Aurum Proptech Other Announcement
Aurum PropTech Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure details the equity distribution across various shareholder categories.
Aurum Proptech Earnings Call Transcript: Key Takeaways
Management is pivoting from 'portfolio' to 'platform' via Housing.com integration, masking a reliance on inorganic growth with aggressive profitability targets for subsidiaries.
Aurum Proptech Management Change
Aurum PropTech Limited announced that Mr. Kunal Karan, the Chief Financial Officer, has been given the additional charge of Chief Risk Officer, effective October 16, 2026.
Aurum Proptech Investor Presentation: Key Takeaways
Aurum PropTech delivered a profitable Q2 FY27 with 57% YoY revenue growth, achieving a PBT of ₹6.60 Cr and 11.5% Adjusted EBITDA margin.
Aurum Proptech Results Update
Aurum PropTech reported a 57% YoY increase in total income to ₹137 crore for Q2 FY27. Adjusted EBITDA margins expanded to 11.5% alongside positive PBT margins.
- Value
- ₹137.0 Cr
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.